Biology and Medicine

Department of Internal Medicine and Endocrine, Faculty of Medicine, University of Tabuk, Saudi Arabia

Biography

Dr. Fakhralddin Abbas Elfakki is an associate professor works at the  Department of Internal Medicine and Endocrine, Faculty of Medicine, University of Tabuk, Saudi Arabia.
 

Publications

• Review Article   
  The Effects of Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT-2-i) on Fatty Liver, Steato-Hepatitis, Liver Fibrosis, and Hepatocellular Carcinoma-A Review
  Author(s): Hyder Osman Mirghani, Thomas Antony Thaniyath* and Fakhralddin Abbas Elfakki
  
  The drug category of Sodium-Glucose co-transporters 2 inhibitors (SGLT 2 inhibitors) is a newer class of pharmaceutical agents for the management of type-2 diabetes mellitus, with a proved promising cardio-protective effects. In addition to above beneficial effects, Sodium-Glucose co-transporters 2 inhibitors showed their effectiveness to reduce abdominal fat content, amount of fat in liver tissues and progression of inflammation and fibrosis in experimental as well as clinical studies. Non-Alcoholic Fatty Liver Diseases (NAFLD) are common among patients with type 2 diabetes patients and includes fatty liver, Non-Alcoholic Steato-Hepatitis (NASH) and cirrhosis and when present together these disorders exacerbates each other deleterious consequences. This review article is carried out with an objectives to find out the effects of Sodium-Glucose co-transporters 2 inhibitors on non-alcoh.. View more»
  

  DOI: 10.35248/0974-8369.19.11.459

  Abstract HTML PDF